At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 224 enrolled
Drug / intervention
Breast conservative surgeryprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano·interventional·Posted Dec 26, 2016·Updated Dec 26, 2016
In Brief
A Phase 2 clinical trial evaluating Breast conservative surgery for Carcinoma Breast. Completed, enrolled 224 participants across 1 site.
Detailed Summary
By this non-randomized prospective study, it's evaluated the outcome of patients underwent BCS for DCIS at whom an established score system to address adjuvant therapies have been prospectively applied, according to the wideness of free margins. Between March 2000 and April 2006, 224 patients were enrolled and followed within the study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCarcinoma Breast
CountriesItaly
Collaborators--
Timeline
Phase 2CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2000
Primary CompletionApr 2006
First PostedDec 2016
TodayJul 2026
First PostedDec 26, 2016
Enrollment StartMar 1, 2000
Primary CompletionApr 1, 2006
TodayJul 2, 2026
Enrollment to primary: 6.1 yearsPosted 9.5 years ago
Interventions
Breast conservative surgeryprocedure